These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 2943536

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Demonstration of the existence of a second, non-lysosomal glucocerebrosidase that is not deficient in Gaucher disease.
    van Weely S, Brandsma M, Strijland A, Tager JM, Aerts JM.
    Biochim Biophys Acta; 1993 Mar 24; 1181(1):55-62. PubMed ID: 8457606
    [Abstract] [Full Text] [Related]

  • 4. Mammalian glucocerebrosidase: implications for Gaucher's disease.
    Glew RH, Basu A, LaMarco KL, Prence EM.
    Lab Invest; 1988 Jan 24; 58(1):5-25. PubMed ID: 3275832
    [No Abstract] [Full Text] [Related]

  • 5. Gaucher disease types 1, 2, and 3: differential mutations of the acid beta-glucosidase active site identified with conduritol B epoxide derivatives and sphingosine.
    Grabowski GA, Dinur T, Osiecki KM, Kruse JR, Legler G, Gatt S.
    Am J Hum Genet; 1985 May 24; 37(3):499-510. PubMed ID: 4003396
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The enzymatic hydrolysis of 6-acylamino-4-methylumbelliferyl-beta-D-glucosides: identification of a novel human acid beta-glucosidase.
    Mikhaylova M, Wiederschain G, Mikhaylov V, Aerts JM.
    Biochim Biophys Acta; 1996 Oct 07; 1317(1):71-9. PubMed ID: 8876629
    [Abstract] [Full Text] [Related]

  • 10. Assay of the beta-glucosidase activity with natural labelled and artificial substrates in leukocytes from homozygotes and heterozygotes with the Norrbottnian type (Type 3) of Gaucher disease.
    Svennerholm L, Håkansson G, Dreborg S.
    Clin Chim Acta; 1980 Sep 25; 106(2):183-93. PubMed ID: 6773705
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Human acid beta-glucosidase. Use of conduritol B epoxide derivatives to investigate the catalytically active normal and Gaucher disease enzymes.
    Grabowski GA, Osiecki-Newman K, Dinur T, Fabbro D, Legler G, Gatt S, Desnick RJ.
    J Biol Chem; 1986 Jun 25; 261(18):8263-9. PubMed ID: 3087971
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Multiple glycosidase deficiencies in a case of juvenile (type 3) Gaucher disease.
    Chiao YB, Hoyson GM, Peters SP, Lee RE, Diven W, Murphy JV, Glew RH.
    Proc Natl Acad Sci U S A; 1978 May 25; 75(5):2448-52. PubMed ID: 27787
    [Abstract] [Full Text] [Related]

  • 18. beta-Glucosidase isoenzymes in Epstein-Barr virus-transformed lymphoid cell lines from normal subjects and patients with type 1 Gaucher disease.
    Maret A, Salvayre R, Samadi M, Douste-Blazy L.
    Enzyme; 1987 May 25; 37(4):208-17. PubMed ID: 3038513
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Gaucher disease. III. Substrate specificity of glucocerebrosidase and the use of nonlabeled natural substrates for the investigation of patients.
    Choy FY, Davidson RG.
    Am J Hum Genet; 1980 Sep 25; 32(5):670-80. PubMed ID: 6775530
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.